Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409
- 12 May 1994
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 257 (1-2) , 123-130
- https://doi.org/10.1016/0014-2999(94)90703-x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- A common enzyme may be responsible for the conversion of organic nitrates to nitric oxide in vascular microsomesBiochemical and Biophysical Research Communications, 1992
- Reduction of biological effluents in purge and trap micro reaction vessels and detection of endothelium-derived nitric oxide (edno) by chemiluminescenceJournal of Molecular and Cellular Cardiology, 1991
- Characteristics of the Vasorelaxing Action of (3E)-4-Ethyl-2-Hydroximino-5-Nitro-3-Hexamide FK409, a New Vasodilator Isolated From Microbial Sources, in Isolated Rabbit ArteriesJournal of Cardiovascular Pharmacology, 1991
- The Biochemical Pathways of Nitric Oxide Formation from NitrovasodilatorsJournal of Cardiovascular Pharmacology, 1991
- Inhibition of platelet-derived mitogen release by nitric oxide (EDRF)Inflammation Research, 1989
- Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.Journal of Clinical Investigation, 1989
- Quantitative and kinetic characterization of nitric oxide and EDRF released from cultured endothelial cellsBiochemical and Biophysical Research Communications, 1988
- Comparative pharmacology of EDRF and nitric oxide on vascular stripsEuropean Journal of Pharmacology, 1987
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Determination of the Oil/ Water Distribution Coefficients of Glyceryl Trinitrate and Two Similar Nitrate EstersJournal of Pharmaceutical Sciences, 1963